Dr. William J. Harmon, MD

Dr. Harmon practices at Urology Partners of North Texas in Arlington, Texas.

Dr. Harmon's NPI, 1104806207, was assigned on January 17, 2006. Dr. Harmon graduated from Pritzker School of Medicine in 1991. Dr. Harmon's Texas license number on file is L1065.

Dr. Harmon's primary practice is Urology Partners of North Texas, at 5001 S Cooper St, Arlington, TX 76017 in Tarrant County. The practice phone is (866) 367-8768.

Dr. Harmon's primary practice is Urology Partners of North Texas in Arlington, Texas. Dr. Harmon is also affiliated with Methodist Hospital. The medical group on file is Urology Partners of North Texas. Dmand AI also links Dr. Harmon to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Harmon practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Harmon's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Harmon is board certified in urology by the American Board of Urology. Dmand AI has Dr. Harmon's licenses on file in 2 states: Texas and Minnesota.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and testicular dysfunction among the conditions Dr. Harmon treats.

CMS data shows 3,091 Medicare services from Dr. Harmon across 27 procedure codes in 2024, for 724 Medicare patients. Medicare paid $135,190 for them.

CMS counts 724 Medicare patients who saw Dr. Harmon in 2024. The largest group is 65 to 74, with 335 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Harmon's median patient age at 70, with 32% women.

In 2024, Dr. Harmon wrote 2,099 Medicare Part D claims for 597 patients. 91% of them were for generic drugs. CMS names the drug for 1,943 of them, across 27 drugs with 11 or more claims each, at $243,347 in total drug cost. In 2023, CMS named 1,657 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Harmon for performance year 2024, reported as part of a group. Dr. Harmon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Harmon as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Harmon, more than 69% of the clinicians it reports for that procedure.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 16 papers to Dr. Harmon, published from 2015 to 2017. 2015 was the busiest year, with 2. The most frequent topics are Urinary Bladder, Kidney Neoplasms and Adenoma, Oxyphilic. Dr. Harmon has published most often in J Urol. Dr. Harmon's most frequent co-authors are Jay T. Bishoff, MD, John Andrew Abikhaled, MD and David G. Bostwick, MD, MBA.

CMS Open Payments shows 237 general payments to Dr. Harmon from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Pacira Pharmaceuticals Incorporated paid the most, $25,790.

Dmand AI lists 2 awards for Dr. Harmon, most recently CMS Stage 1 2012 in 2011.

Dr. Harmon graduated from Pritzker School of Medicine in 1991.

Dr. Harmon is in network with 19 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.